+MOREAbout Us

Biosynergics values quality and efficiency in all of its services. With more than over 100 cases of antibody development services to pharmaceutical businesses a...

+MOREPlatform

Based on its proprietary antibody technology platforms (H3 antibody technology, Synergistic Antibody technology [SynAbTM]), BSI is committed to the development ...

Company News

Biosynergics, Inc. Completes Series A Financing and Company Restructuring. —On October 29, 2017, Biosynergics, Inc., a China-based startup biotech...

More>>

New Products

【NEW!】Mouse anti-Human HER2/ErbB2 Monoclonal Antibody

More>>
ADD(Biosion)
IVD Raw Materials
For further information, please scan the QR code to follow us.
About us|Technology|Therapeutics|Diagnostics|Support|Contact Us
copyright 2015 Biosynergics Inc 苏ICP备13049856号-1